secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2026-04-06T23:59:59+00:00
Accession:  0001213900-26-040474
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Citius shareholders elect seven directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Mazur, Holubiak, Dutia, Holuka, McGrath, Smith, Webb.
- Broker non-votes of ~6.66M shares on each director; no broker non-votes on auditor ratification.
- Ratification of Wolf & Company as auditor: 8,593,946 for, 855,866 against, 673,867 abstain.
- Directors serve one-year term expiring at 2027 annual meeting or until successors qualified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026040474/0001213900-26-040474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026040474/ea0285222-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-040474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer